Market Tracker

04/29 5:16pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

139.28
Delayed Data
As of Apr 29
 -3.25 / -2.28%
Today’s Change
124.16
Today|||52-Week Range
208.88
-26.98%
Year-to-Date

Today’s Trading

Previous close142.53
Today’s open141.88
Day’s range137.40 - 142.31
Volume2,051,577
Average volume (3 months)1,733,050
Market cap$32.0B
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-79.45%
Earnings growth (this year)+3.66%
Earnings growth (next 5 years)+21.51%
Revenue growth (last year)+12.25%
P/E ratio208.3
Price/Sales16.57
Price/Book3.89

Competitors

 Today’s
change
Today’s
% change
SHPGShire+6.46+3.57%
ZTSZoetis Inc-0.16-0.34%
VRTXVertex Pharmaceutica...-2.41-2.78%
MYLMylan NV-0.89-2.09%
Data as of 4:01pm ET, 04/29/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$1.25
Annual revenue (last year)$2.5B
Annual profit (last year)$144.4M
Net profit margin5.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
Cheshire, Connecticut

Forecasts